AR090580A1 - PHARMACEUTICAL COMPOSITIONS FOR COMBINED THERAPY - Google Patents
PHARMACEUTICAL COMPOSITIONS FOR COMBINED THERAPYInfo
- Publication number
- AR090580A1 AR090580A1 ARP130101075A AR090580A1 AR 090580 A1 AR090580 A1 AR 090580A1 AR P130101075 A ARP130101075 A AR P130101075A AR 090580 A1 AR090580 A1 AR 090580A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical compositions
- tetrabenazine
- combined therapy
- movement disorders
- pridopidine
- Prior art date
Links
Abstract
Composiciones farmacéuticas que comprenden una combinación terapéuticamente eficaz de un estabilizador dopaminérgico conocido como pridopidina, y un inhibidor del transportador vesicular de monoamina tipo 2 (VMAT) conocido como tetrabenazina. Las composiciones farmacéuticas son útiles para mejorar los efectos terapéuticos sintomáticos, y para reducir los efectos adversos, de tetrabenazina en el tratamiento de los trastornos de movimiento, y en particular los trastornos de movimiento asociados con la enfermedad de Huntington, síndrome de Gilles de la Tourette, o disquinesia tardía.Pharmaceutical compositions comprising a therapeutically effective combination of a dopamine stabilizer known as pridopidine, and an inhibitor of the vesicular monoamine transporter type 2 (VMAT) known as tetrabenazine. The pharmaceutical compositions are useful for improving symptomatic therapeutic effects, and for reducing the adverse effects, of tetrabenazine in the treatment of movement disorders, and in particular movement disorders associated with Huntington's disease, Gilles de la Tourette syndrome , or tardive dyskinesia.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261620203P | 2012-04-04 | 2012-04-04 | |
US201261625192P | 2012-04-17 | 2012-04-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR090580A1 true AR090580A1 (en) | 2014-11-19 |
Family
ID=49773120
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP130101075 AR090580A1 (en) | 2012-04-04 | 2013-04-03 | PHARMACEUTICAL COMPOSITIONS FOR COMBINED THERAPY |
Country Status (3)
Country | Link |
---|---|
AR (1) | AR090580A1 (en) |
TW (1) | TW201345528A (en) |
UY (1) | UY34728A (en) |
-
2013
- 2013-04-01 TW TW102111748A patent/TW201345528A/en unknown
- 2013-04-03 AR ARP130101075 patent/AR090580A1/en unknown
- 2013-04-04 UY UY34728A patent/UY34728A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TW201345528A (en) | 2013-11-16 |
UY34728A (en) | 2013-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2020003478A2 (en) | Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1) inhibitors and their uses | |
CO2017004525A2 (en) | Ror-gamma inhibitory dihydropyrrolopyridines | |
BR112014024672A8 (en) | PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY | |
CO2018012482A2 (en) | Formulations of an lsd1 inhibitor | |
DOP2019000005A (en) | 3-METIL PIRAZINAS 2,5-DISUSTITUIDAS AND 3-METIL PIRAZINAS 2,5,6-TRISUSTITUIDAS AS ALLOSTERIC INHIBITORS OF SHP2 | |
CO2019007810A2 (en) | Amino-triazolopyridine compounds and their use in the treatment of cancer | |
MX2020004467A (en) | Methods for treating or preventing asthma by administering an il-4r antagonist. | |
SV2015005115A (en) | DERIVATIVES OF PIRAZOLOPIRROLIDINE AND ITS USE IN THE TREATMENT OF DISEASES | |
CR20160518A (en) | COMPOUNDS TO TREAT SPINAL MUSCLE ATROPHY | |
AR107871A1 (en) | COMBINATIONS OF LSD1 INHIBITORS FOR USE IN THE TREATMENT OF SOLID TUMORS | |
CR20180232A (en) | PEPTIDE MACROCICLES AGAINST ACINETOBACTER BAUMANNII | |
UY35916A (en) | TRICYCLIC COMPOUNDS AS BROMODOMINUM INHIBITING ANTINEOPLASTIC AGENTS | |
ECSP20046463A (en) | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING DISEASES INVOLVING TISSUES WITH ACIDIC OR HYPOXIC DISEASES | |
ECSP088747A (en) | PIRAZOLES AS INHIBITORS OF THE 11-BETA-HSD1 | |
UY36702A (en) | PIRIDINES REPLACED AND METHODS OF USE | |
CO2019009722A2 (en) | Therapeutic dendrimers | |
CO2021015793A2 (en) | Methods of treating or preventing asthma by administering an il-33 antagonist | |
CL2021001388A1 (en) | Useful compounds in hiv therapy | |
CR20150653A (en) | NEW COMPOUNDS FOR CANCER TREATMENT | |
DOP2019000100A (en) | DERIVATIVES OF NAFTIRIDINONE AND ITS USE IN THE TREATMENT OF ARRITMIA | |
ECSP16086247A (en) | (S) -PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE | |
MX2020004678A (en) | Use of riluzole prodrugs to treat ataxias. | |
ECSP16086232A (en) | (R) -PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE | |
PE20181450A1 (en) | 1,3,4-THADIAZOLE COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER | |
ECSP13012988A (en) | DERIVATIVES OF TIENOPIRIMIDINE (2,3-D) AND ITS USE TO TREAT ARRITMIA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |